From single cell multi-omics to precision medicine with Singleron Biotechnologies.
top of page
Search
Andreas Schmidt, Senior Vice President Global Business Development talked with BioRN about the one-stop-shop solution for single cell...
- Mar 9, 2023
- 1 min
Boehringer Ingelheim (BI) Academy Panel Discussion at BI Innovation Prize reception
The panel discussion at the Boehringer Ingelheim Innovation Prize with the BI Academy topic >>Opportunities and Challenges of a bear...
- Mar 8, 2023
- 3 min
Softlanding completed!
DIVERSA Technologies and BioCat agreement marks new milestone in internationalization thanks to new service BiointeRNational The...
- Mar 6, 2023
- 2 min
Strengthening Germany as a location for innovation, biotechnology and pharmaceuticals, securing EU
March 1st 2023: Seven experts gave an assessment of the topic of funding, the business location Germany and future viability in the...
- Mar 3, 2023
- 8 min
Spatial transcriptomics—the next evolution of cancer drug discovery
Charles Darwin’s theory of evolution was inspired by the diverse species of finches inhabiting the Galápagos Islands. Darwin’s finches...
- Mar 2, 2023
- 1 min
BioRN Lounge with CARMA FUND: Supporting innovators in life sciences for patient benefit
On February 28, BioRN Lounge hosted Martin Raditsch, Managing Partner of CARMA FUND as guest speaker. CARMA FUND is an early-stage...
- Feb 24, 2023
- 3 min
Studying epigenetic regulation at the single-molecule level
In a first-of-its-kind study, EMBL researchers have shown how DNA methylation across the genome contributes to the precise regulation of...
- Feb 24, 2023
- 4 min
UNIVERSITÄT HEIDELBERG WITH 16 “HIGHLY CITED RESEARCHERS”
INTERNATIONAL EVALUATION NAMES RESEARCHERS WHOSE PUBLICATIONS HAVE BEEN MOST CITED WORLDWIDE 16 researchers from Heidelberg University...
- Feb 24, 2023
- 2 min
Metabolic enzyme protects proteins with sulfur
In the cell, additional sulfur atoms are attached to many proteins. Scientists at the German Cancer Research Center have now, for the...
- Feb 24, 2023
- 2 min
Understanding the problems related to animal models
Animal models are non-human species that can be applied to reproduce the disease, diagnosis, and treatment progression that occurs in...
- Feb 24, 2023
- 2 min
AI Hub - The Medical Brick: Challenges in Drug Discovery
Drug discovery is the process of identifying new compounds that can be used as medicines to treat or prevent diseases. The process of...
- Feb 20, 2023
- 1 min
Innovation in Cancer Therapies “made in” Heidelberg Pharma
Last week on February 15th, BioRN visited Heidelberg Pharma AG in Ladenburg to interview Artjom Wischnjow, Associate Director Business...
bottom of page